Source:http://linkedlifedata.com/resource/pubmed/id/10233320
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2000-3-27
|
pubmed:abstractText |
Excessive axillary hyperhidrosis is a socially embarrassing condition which severely reduces quality of life and may result in psychological disturbance. Available treatment strategies do not resolve the problem in all cases. Intracutaneous injections of botulinum A toxin have been shown to be effective in patients with local sweating disorders. We performed a randomized, double-blind, within-group comparison in 13 individuals (nine women and four men) with severe axillary hyperhidrosis resistant to conventional treatment, to study the effect of intracutaneous injections of botulinum toxin on sweating. A total dose of 200 mouse units of botulinum A toxin (Dysport(R)) was injected into six different sites in one axilla, whereas the other was injected with sterile saline. Objective quantification of sweat production was performed using digitized ninhydrin-stained sheets. Three weeks after treatment, the mean difference in ninhydrin staining between botulinum-treated and placebo-treated axillae was -34.5% (P < 0.001), after 8 weeks -36.9% (P < 0.001) and after 13 weeks -28.4% (P < 0.001). Subjective rating of sweat production was evaluated on a visual analogue scale (0, no sweating, to 100, most severe sweating). Three weeks after treatment the difference between the botulinum-treated and placebo-treated axillae was -56.5% (P < 0.001), after 8 weeks -67.4% (P < 0.001) and after 13 weeks -62.5% (P < 0.001). No serious side-effects were observed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0007-0963
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
677-80
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10233320-Adult,
pubmed-meshheading:10233320-Axilla,
pubmed-meshheading:10233320-Botulinum Toxins, Type A,
pubmed-meshheading:10233320-Double-Blind Method,
pubmed-meshheading:10233320-Female,
pubmed-meshheading:10233320-Humans,
pubmed-meshheading:10233320-Hyperhidrosis,
pubmed-meshheading:10233320-Injections, Intradermal,
pubmed-meshheading:10233320-Male,
pubmed-meshheading:10233320-Middle Aged,
pubmed-meshheading:10233320-Neuromuscular Blocking Agents,
pubmed-meshheading:10233320-Sweating
|
pubmed:year |
1999
|
pubmed:articleTitle |
A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.
|
pubmed:affiliation |
Division of Neurological Rehabilitation, Department of Neurology, University of Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|